nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—coronary artery disease	0.295	1	CiPCiCtD
Celecoxib—systemic lupus erythematosus—Acetylsalicylic acid—coronary artery disease	0.0962	0.533	CpDpCtD
Celecoxib—MAPK14—coronary artery disease	0.0927	0.488	CbGaD
Celecoxib—CA5B—coronary artery disease	0.0771	0.406	CbGaD
Celecoxib—rheumatoid arthritis—Acetylsalicylic acid—coronary artery disease	0.0496	0.275	CpDpCtD
Celecoxib—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.0347	0.192	CpDpCtD
Celecoxib—CA14—Furosemide—coronary artery disease	0.0126	0.065	CbGbCtD
Celecoxib—CA6—Furosemide—coronary artery disease	0.0119	0.0618	CbGbCtD
Celecoxib—CA5A—Furosemide—coronary artery disease	0.0119	0.0618	CbGbCtD
Celecoxib—ORM1—Penbutolol—coronary artery disease	0.0113	0.0584	CbGbCtD
Celecoxib—PTGS2—coronary artery disease	0.0106	0.0558	CbGaD
Celecoxib—CA5B—Furosemide—coronary artery disease	0.0104	0.0538	CbGbCtD
Celecoxib—ORM1—Pitavastatin—coronary artery disease	0.00985	0.051	CbGbCtD
Celecoxib—ALB—coronary artery disease	0.00943	0.0497	CbGaD
Celecoxib—CA12—Furosemide—coronary artery disease	0.00892	0.0462	CbGbCtD
Celecoxib—CA9—Furosemide—coronary artery disease	0.00892	0.0462	CbGbCtD
Celecoxib—ABCC4—Rosuvastatin—coronary artery disease	0.00824	0.0427	CbGbCtD
Celecoxib—CA4—Furosemide—coronary artery disease	0.00785	0.0406	CbGbCtD
Celecoxib—CA2—Furosemide—coronary artery disease	0.00721	0.0374	CbGbCtD
Celecoxib—ABCC4—Atorvastatin—coronary artery disease	0.00683	0.0354	CbGbCtD
Celecoxib—CA5B—cervicothoracic ganglion—coronary artery disease	0.00513	0.297	CbGeAlD
Celecoxib—PTGS2—Acetylsalicylic acid—coronary artery disease	0.00472	0.0245	CbGbCtD
Celecoxib—ALB—Pitavastatin—coronary artery disease	0.00414	0.0215	CbGbCtD
Celecoxib—ALB—Valsartan—coronary artery disease	0.00403	0.0209	CbGbCtD
Celecoxib—CYP2C9—Fenofibrate—coronary artery disease	0.00369	0.0191	CbGbCtD
Celecoxib—CA5B—sinoatrial node—coronary artery disease	0.00331	0.191	CbGeAlD
Celecoxib—ALB—Rosuvastatin—coronary artery disease	0.00306	0.0158	CbGbCtD
Celecoxib—ALB—Acetylsalicylic acid—coronary artery disease	0.00298	0.0154	CbGbCtD
Celecoxib—CYP2C9—Gemfibrozil—coronary artery disease	0.00295	0.0153	CbGbCtD
Celecoxib—ALB—Captopril—coronary artery disease	0.00294	0.0152	CbGbCtD
Celecoxib—CYP2C9—Clopidogrel—coronary artery disease	0.00256	0.0132	CbGbCtD
Celecoxib—CYP3A4—Ticagrelor—coronary artery disease	0.00241	0.0125	CbGbCtD
Celecoxib—ALB—Furosemide—coronary artery disease	0.00236	0.0122	CbGbCtD
Celecoxib—ALB—Losartan—coronary artery disease	0.00232	0.012	CbGbCtD
Celecoxib—CYP2C9—Pitavastatin—coronary artery disease	0.00223	0.0116	CbGbCtD
Celecoxib—CYP2C9—Valsartan—coronary artery disease	0.00217	0.0113	CbGbCtD
Celecoxib—CYP3A4—Fenofibrate—coronary artery disease	0.00214	0.0111	CbGbCtD
Celecoxib—CYP2D6—Niacin—coronary artery disease	0.00177	0.00917	CbGbCtD
Celecoxib—CYP3A4—Gemfibrozil—coronary artery disease	0.00171	0.00888	CbGbCtD
Celecoxib—CYP2C9—cardial valve—coronary artery disease	0.00169	0.0977	CbGeAlD
Celecoxib—CYP2C9—Rosuvastatin—coronary artery disease	0.00165	0.00853	CbGbCtD
Celecoxib—CYP2D6—Timolol—coronary artery disease	0.00165	0.00853	CbGbCtD
Celecoxib—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0016	0.00831	CbGbCtD
Celecoxib—CYP2C9—Simvastatin—coronary artery disease	0.00153	0.00793	CbGbCtD
Celecoxib—CYP2C9—Lovastatin—coronary artery disease	0.0015	0.00776	CbGbCtD
Celecoxib—CYP2C9—Pravastatin—coronary artery disease	0.0015	0.00776	CbGbCtD
Celecoxib—CYP3A4—Clopidogrel—coronary artery disease	0.00149	0.0077	CbGbCtD
Celecoxib—CYP2D6—Captopril—coronary artery disease	0.00145	0.00751	CbGbCtD
Celecoxib—CYP2D6—Simvastatin—coronary artery disease	0.0014	0.00725	CbGbCtD
Celecoxib—CYP3A4—Eplerenone—coronary artery disease	0.00138	0.00715	CbGbCtD
Celecoxib—CYP2D6—Pravastatin—coronary artery disease	0.00137	0.00709	CbGbCtD
Celecoxib—CYP2D6—Lovastatin—coronary artery disease	0.00137	0.00709	CbGbCtD
Celecoxib—CYP2C9—Atorvastatin—coronary artery disease	0.00136	0.00707	CbGbCtD
Celecoxib—CYP2C9—Losartan—coronary artery disease	0.00125	0.00646	CbGbCtD
Celecoxib—CYP2D6—Atorvastatin—coronary artery disease	0.00125	0.00646	CbGbCtD
Celecoxib—CYP3A4—Enalapril—coronary artery disease	0.00123	0.00638	CbGbCtD
Celecoxib—CYP3A4—Rosuvastatin—coronary artery disease	0.000958	0.00496	CbGbCtD
Celecoxib—CYP3A4—Ezetimibe—coronary artery disease	0.000958	0.00496	CbGbCtD
Celecoxib—Etoricoxib—MAPK14—coronary artery disease	0.000922	0.771	CrCbGaD
Celecoxib—CYP3A4—Simvastatin—coronary artery disease	0.00089	0.00461	CbGbCtD
Celecoxib—CYP3A4—Lovastatin—coronary artery disease	0.000871	0.00451	CbGbCtD
Celecoxib—CYP3A4—Pravastatin—coronary artery disease	0.000871	0.00451	CbGbCtD
Celecoxib—CYP3A4—Atorvastatin—coronary artery disease	0.000794	0.00411	CbGbCtD
Celecoxib—PDPK1—myocardium—coronary artery disease	0.000759	0.0439	CbGeAlD
Celecoxib—CYP3A4—Losartan—coronary artery disease	0.000726	0.00376	CbGbCtD
Celecoxib—PDPK1—heart—coronary artery disease	0.00053	0.0306	CbGeAlD
Celecoxib—CA14—cardiac ventricle—coronary artery disease	0.00042	0.0243	CbGeAlD
Celecoxib—PDPK1—blood—coronary artery disease	0.000395	0.0229	CbGeAlD
Celecoxib—MAPK14—heart—coronary artery disease	0.000283	0.0164	CbGeAlD
Celecoxib—CA14—heart—coronary artery disease	0.000276	0.0159	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—coronary artery disease	0.000267	0.0155	CbGeAlD
Celecoxib—CA14—cardiac atrium—coronary artery disease	0.000236	0.0136	CbGeAlD
Celecoxib—PTGS2—artery—coronary artery disease	0.000221	0.0128	CbGeAlD
Celecoxib—MAPK14—blood—coronary artery disease	0.000211	0.0122	CbGeAlD
Celecoxib—CA4—cardiac ventricle—coronary artery disease	0.000203	0.0117	CbGeAlD
Celecoxib—CA5B—heart—coronary artery disease	0.000193	0.0112	CbGeAlD
Celecoxib—CA4—myocardium—coronary artery disease	0.000191	0.011	CbGeAlD
Celecoxib—PTGS2—endothelium—coronary artery disease	0.000187	0.0108	CbGeAlD
Celecoxib—CA5B—cardiovascular system—coronary artery disease	0.000182	0.0105	CbGeAlD
Celecoxib—Etoricoxib—CYP2C19—coronary artery disease	0.000169	0.141	CrCbGaD
Celecoxib—CA2—cardiac ventricle—coronary artery disease	0.000168	0.00972	CbGeAlD
Celecoxib—CA5B—cardiac atrium—coronary artery disease	0.000165	0.00954	CbGeAlD
Celecoxib—CA2—myocardium—coronary artery disease	0.000158	0.00915	CbGeAlD
Celecoxib—ALB—heart—coronary artery disease	0.00015	0.00865	CbGeAlD
Celecoxib—ABCC4—heart—coronary artery disease	0.000145	0.00837	CbGeAlD
Celecoxib—CA5B—blood—coronary artery disease	0.000144	0.00832	CbGeAlD
Celecoxib—CA4—heart—coronary artery disease	0.000133	0.0077	CbGeAlD
Celecoxib—ORM1—blood—coronary artery disease	0.000127	0.00736	CbGeAlD
Celecoxib—CA4—cardiovascular system—coronary artery disease	0.000126	0.00726	CbGeAlD
Celecoxib—CA4—cardiac atrium—coronary artery disease	0.000114	0.00658	CbGeAlD
Celecoxib—CA2—heart—coronary artery disease	0.00011	0.00638	CbGeAlD
Celecoxib—ABCC4—blood—coronary artery disease	0.000108	0.00625	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—coronary artery disease	0.000105	0.088	CrCbGaD
Celecoxib—CA2—cardiovascular system—coronary artery disease	0.000104	0.00602	CbGeAlD
Celecoxib—CA4—blood—coronary artery disease	9.93e-05	0.00574	CbGeAlD
Celecoxib—CA2—cardiac atrium—coronary artery disease	9.44e-05	0.00546	CbGeAlD
Celecoxib—CYP2C9—heart—coronary artery disease	9.34e-05	0.0054	CbGeAlD
Celecoxib—CYP2C9—cardiovascular system—coronary artery disease	8.81e-05	0.0051	CbGeAlD
Celecoxib—CA2—blood—coronary artery disease	8.23e-05	0.00476	CbGeAlD
Celecoxib—PTGS2—heart—coronary artery disease	8.15e-05	0.00471	CbGeAlD
Celecoxib—PTGS2—cardiovascular system—coronary artery disease	7.69e-05	0.00445	CbGeAlD
Celecoxib—CYP2C9—blood—coronary artery disease	6.97e-05	0.00403	CbGeAlD
Celecoxib—PTGS2—blood—coronary artery disease	6.08e-05	0.00352	CbGeAlD
Celecoxib—CYP3A4—blood—coronary artery disease	5.31e-05	0.00307	CbGeAlD
Celecoxib—CYP2D6—blood—coronary artery disease	5.23e-05	0.00302	CbGeAlD
Celecoxib—Body temperature increased—Captopril—coronary artery disease	1.15e-05	0.000164	CcSEcCtD
Celecoxib—Dizziness—Simvastatin—coronary artery disease	1.15e-05	0.000163	CcSEcCtD
Celecoxib—Rash—Ezetimibe—coronary artery disease	1.15e-05	0.000163	CcSEcCtD
Celecoxib—Dermatitis—Ezetimibe—coronary artery disease	1.15e-05	0.000163	CcSEcCtD
Celecoxib—Confusional state—Ramipril—coronary artery disease	1.14e-05	0.000163	CcSEcCtD
Celecoxib—Asthenia—Niacin—coronary artery disease	1.14e-05	0.000163	CcSEcCtD
Celecoxib—Fatigue—Losartan—coronary artery disease	1.14e-05	0.000162	CcSEcCtD
Celecoxib—Headache—Ezetimibe—coronary artery disease	1.14e-05	0.000162	CcSEcCtD
Celecoxib—Anaphylactic shock—Ramipril—coronary artery disease	1.14e-05	0.000162	CcSEcCtD
Celecoxib—Oedema—Ramipril—coronary artery disease	1.14e-05	0.000162	CcSEcCtD
Celecoxib—Vertigo—Lisinopril—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Dry mouth—Timolol—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Constipation—Losartan—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Syncope—Lisinopril—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Vomiting—Eplerenone—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Feeling abnormal—Furosemide—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Leukopenia—Lisinopril—coronary artery disease	1.13e-05	0.000161	CcSEcCtD
Celecoxib—Nausea—Fenofibrate—coronary artery disease	1.13e-05	0.00016	CcSEcCtD
Celecoxib—Pruritus—Niacin—coronary artery disease	1.13e-05	0.00016	CcSEcCtD
Celecoxib—Asthenia—Pravastatin—coronary artery disease	1.12e-05	0.00016	CcSEcCtD
Celecoxib—Gastrointestinal pain—Furosemide—coronary artery disease	1.12e-05	0.00016	CcSEcCtD
Celecoxib—Rash—Eplerenone—coronary artery disease	1.12e-05	0.00016	CcSEcCtD
Celecoxib—Urticaria—Perindopril—coronary artery disease	1.12e-05	0.00016	CcSEcCtD
Celecoxib—Hypersensitivity—Trandolapril—coronary artery disease	1.12e-05	0.00016	CcSEcCtD
Celecoxib—Dermatitis—Eplerenone—coronary artery disease	1.12e-05	0.00016	CcSEcCtD
Celecoxib—Diarrhoea—Valsartan—coronary artery disease	1.12e-05	0.000159	CcSEcCtD
Celecoxib—Confusional state—Timolol—coronary artery disease	1.12e-05	0.000159	CcSEcCtD
Celecoxib—Shock—Ramipril—coronary artery disease	1.12e-05	0.000159	CcSEcCtD
Celecoxib—Hypersensitivity—Enalapril—coronary artery disease	1.12e-05	0.000159	CcSEcCtD
Celecoxib—Abdominal pain—Perindopril—coronary artery disease	1.12e-05	0.000159	CcSEcCtD
Celecoxib—Body temperature increased—Perindopril—coronary artery disease	1.12e-05	0.000159	CcSEcCtD
Celecoxib—Palpitations—Lisinopril—coronary artery disease	1.11e-05	0.000159	CcSEcCtD
Celecoxib—Diarrhoea—Olmesartan—coronary artery disease	1.11e-05	0.000159	CcSEcCtD
Celecoxib—Headache—Eplerenone—coronary artery disease	1.11e-05	0.000159	CcSEcCtD
Celecoxib—Nervous system disorder—Ramipril—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Thrombocytopenia—Ramipril—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Anaphylactic shock—Timolol—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Oedema—Timolol—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Pruritus—Pravastatin—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Loss of consciousness—Lisinopril—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Nausea—Clopidogrel—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Tachycardia—Ramipril—coronary artery disease	1.11e-05	0.000158	CcSEcCtD
Celecoxib—Skin disorder—Ramipril—coronary artery disease	1.1e-05	0.000157	CcSEcCtD
Celecoxib—Infection—Timolol—coronary artery disease	1.1e-05	0.000157	CcSEcCtD
Celecoxib—Vomiting—Simvastatin—coronary artery disease	1.1e-05	0.000157	CcSEcCtD
Celecoxib—Hypersensitivity—Telmisartan—coronary artery disease	1.1e-05	0.000157	CcSEcCtD
Celecoxib—Cough—Lisinopril—coronary artery disease	1.1e-05	0.000157	CcSEcCtD
Celecoxib—Nausea—Lovastatin—coronary artery disease	1.1e-05	0.000157	CcSEcCtD
Celecoxib—Hyperhidrosis—Ramipril—coronary artery disease	1.1e-05	0.000156	CcSEcCtD
Celecoxib—Rash—Simvastatin—coronary artery disease	1.09e-05	0.000156	CcSEcCtD
Celecoxib—Dermatitis—Simvastatin—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Asthenia—Trandolapril—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Shock—Timolol—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Feeling abnormal—Losartan—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Urticaria—Furosemide—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Diarrhoea—Niacin—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Nervous system disorder—Timolol—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Asthenia—Enalapril—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Headache—Simvastatin—coronary artery disease	1.09e-05	0.000155	CcSEcCtD
Celecoxib—Abdominal pain—Furosemide—coronary artery disease	1.08e-05	0.000154	CcSEcCtD
Celecoxib—Body temperature increased—Furosemide—coronary artery disease	1.08e-05	0.000154	CcSEcCtD
Celecoxib—Gastrointestinal pain—Losartan—coronary artery disease	1.08e-05	0.000154	CcSEcCtD
Celecoxib—Dizziness—Valsartan—coronary artery disease	1.08e-05	0.000154	CcSEcCtD
Celecoxib—Anorexia—Ramipril—coronary artery disease	1.08e-05	0.000154	CcSEcCtD
Celecoxib—Nausea—Ezetimibe—coronary artery disease	1.08e-05	0.000154	CcSEcCtD
Celecoxib—Skin disorder—Timolol—coronary artery disease	1.08e-05	0.000153	CcSEcCtD
Celecoxib—Dizziness—Olmesartan—coronary artery disease	1.08e-05	0.000153	CcSEcCtD
Celecoxib—Pruritus—Trandolapril—coronary artery disease	1.08e-05	0.000153	CcSEcCtD
Celecoxib—Arthralgia—Lisinopril—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Myalgia—Lisinopril—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Chest pain—Lisinopril—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Hyperhidrosis—Timolol—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Asthenia—Telmisartan—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Pruritus—Enalapril—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Diarrhoea—Pravastatin—coronary artery disease	1.07e-05	0.000153	CcSEcCtD
Celecoxib—Anxiety—Lisinopril—coronary artery disease	1.07e-05	0.000152	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.07e-05	0.000152	CcSEcCtD
Celecoxib—Anorexia—Timolol—coronary artery disease	1.06e-05	0.000151	CcSEcCtD
Celecoxib—Pruritus—Telmisartan—coronary artery disease	1.06e-05	0.000151	CcSEcCtD
Celecoxib—Nausea—Eplerenone—coronary artery disease	1.06e-05	0.00015	CcSEcCtD
Celecoxib—Dizziness—Niacin—coronary artery disease	1.05e-05	0.00015	CcSEcCtD
Celecoxib—Urticaria—Losartan—coronary artery disease	1.05e-05	0.00015	CcSEcCtD
Celecoxib—Dry mouth—Lisinopril—coronary artery disease	1.05e-05	0.000149	CcSEcCtD
Celecoxib—Abdominal pain—Losartan—coronary artery disease	1.05e-05	0.000149	CcSEcCtD
Celecoxib—Body temperature increased—Losartan—coronary artery disease	1.05e-05	0.000149	CcSEcCtD
Celecoxib—Asthenia—Captopril—coronary artery disease	1.04e-05	0.000148	CcSEcCtD
Celecoxib—Diarrhoea—Trandolapril—coronary artery disease	1.04e-05	0.000148	CcSEcCtD
Celecoxib—Vomiting—Valsartan—coronary artery disease	1.04e-05	0.000148	CcSEcCtD
Celecoxib—Confusional state—Lisinopril—coronary artery disease	1.04e-05	0.000148	CcSEcCtD
Celecoxib—Diarrhoea—Enalapril—coronary artery disease	1.04e-05	0.000148	CcSEcCtD
Celecoxib—Dizziness—Pravastatin—coronary artery disease	1.04e-05	0.000147	CcSEcCtD
Celecoxib—Vomiting—Olmesartan—coronary artery disease	1.04e-05	0.000147	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Celecoxib—Rash—Valsartan—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Celecoxib—Dermatitis—Valsartan—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Celecoxib—Nausea—Simvastatin—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Celecoxib—Anaphylactic shock—Lisinopril—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Celecoxib—Oedema—Lisinopril—coronary artery disease	1.03e-05	0.000147	CcSEcCtD
Celecoxib—Pruritus—Captopril—coronary artery disease	1.03e-05	0.000146	CcSEcCtD
Celecoxib—Rash—Olmesartan—coronary artery disease	1.03e-05	0.000146	CcSEcCtD
Celecoxib—Insomnia—Ramipril—coronary artery disease	1.03e-05	0.000146	CcSEcCtD
Celecoxib—Dermatitis—Olmesartan—coronary artery disease	1.03e-05	0.000146	CcSEcCtD
Celecoxib—Headache—Valsartan—coronary artery disease	1.03e-05	0.000146	CcSEcCtD
Celecoxib—Diarrhoea—Telmisartan—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Celecoxib—Infection—Lisinopril—coronary artery disease	1.02e-05	0.000146	CcSEcCtD
Celecoxib—Headache—Olmesartan—coronary artery disease	1.02e-05	0.000145	CcSEcCtD
Celecoxib—Paraesthesia—Ramipril—coronary artery disease	1.02e-05	0.000145	CcSEcCtD
Celecoxib—Shock—Lisinopril—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Asthenia—Perindopril—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Dyspnoea—Ramipril—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Vomiting—Niacin—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Timolol—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Hypersensitivity—Furosemide—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Somnolence—Ramipril—coronary artery disease	1.01e-05	0.000144	CcSEcCtD
Celecoxib—Thrombocytopenia—Lisinopril—coronary artery disease	1.01e-05	0.000143	CcSEcCtD
Celecoxib—Dizziness—Trandolapril—coronary artery disease	1.01e-05	0.000143	CcSEcCtD
Celecoxib—Tachycardia—Lisinopril—coronary artery disease	1e-05	0.000143	CcSEcCtD
Celecoxib—Insomnia—Timolol—coronary artery disease	1e-05	0.000143	CcSEcCtD
Celecoxib—Rash—Niacin—coronary artery disease	1e-05	0.000143	CcSEcCtD
Celecoxib—Dermatitis—Niacin—coronary artery disease	1e-05	0.000143	CcSEcCtD
Celecoxib—Dizziness—Enalapril—coronary artery disease	1e-05	0.000143	CcSEcCtD
Celecoxib—Skin disorder—Lisinopril—coronary artery disease	1e-05	0.000142	CcSEcCtD
Celecoxib—Dyspepsia—Ramipril—coronary artery disease	9.99e-06	0.000142	CcSEcCtD
Celecoxib—Pruritus—Perindopril—coronary artery disease	9.99e-06	0.000142	CcSEcCtD
Celecoxib—Headache—Niacin—coronary artery disease	9.97e-06	0.000142	CcSEcCtD
Celecoxib—Paraesthesia—Timolol—coronary artery disease	9.97e-06	0.000142	CcSEcCtD
Celecoxib—Vomiting—Pravastatin—coronary artery disease	9.97e-06	0.000142	CcSEcCtD
Celecoxib—Hyperhidrosis—Lisinopril—coronary artery disease	9.95e-06	0.000142	CcSEcCtD
Celecoxib—Diarrhoea—Captopril—coronary artery disease	9.95e-06	0.000142	CcSEcCtD
Celecoxib—Dyspnoea—Timolol—coronary artery disease	9.9e-06	0.000141	CcSEcCtD
Celecoxib—Dizziness—Telmisartan—coronary artery disease	9.89e-06	0.000141	CcSEcCtD
Celecoxib—Rash—Pravastatin—coronary artery disease	9.88e-06	0.000141	CcSEcCtD
Celecoxib—Dermatitis—Pravastatin—coronary artery disease	9.87e-06	0.000141	CcSEcCtD
Celecoxib—Decreased appetite—Ramipril—coronary artery disease	9.87e-06	0.00014	CcSEcCtD
Celecoxib—Somnolence—Timolol—coronary artery disease	9.87e-06	0.00014	CcSEcCtD
Celecoxib—Asthenia—Furosemide—coronary artery disease	9.85e-06	0.00014	CcSEcCtD
Celecoxib—Headache—Pravastatin—coronary artery disease	9.82e-06	0.00014	CcSEcCtD
Celecoxib—Anorexia—Lisinopril—coronary artery disease	9.82e-06	0.00014	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Ramipril—coronary artery disease	9.8e-06	0.000139	CcSEcCtD
Celecoxib—Fatigue—Ramipril—coronary artery disease	9.79e-06	0.000139	CcSEcCtD
Celecoxib—Dyspepsia—Timolol—coronary artery disease	9.77e-06	0.000139	CcSEcCtD
Celecoxib—Hypersensitivity—Losartan—coronary artery disease	9.76e-06	0.000139	CcSEcCtD
Celecoxib—Nausea—Valsartan—coronary artery disease	9.73e-06	0.000138	CcSEcCtD
Celecoxib—Pruritus—Furosemide—coronary artery disease	9.71e-06	0.000138	CcSEcCtD
Celecoxib—Constipation—Ramipril—coronary artery disease	9.71e-06	0.000138	CcSEcCtD
Celecoxib—Nausea—Olmesartan—coronary artery disease	9.68e-06	0.000138	CcSEcCtD
Celecoxib—Vomiting—Trandolapril—coronary artery disease	9.68e-06	0.000138	CcSEcCtD
Celecoxib—Diarrhoea—Perindopril—coronary artery disease	9.66e-06	0.000137	CcSEcCtD
Celecoxib—Decreased appetite—Timolol—coronary artery disease	9.65e-06	0.000137	CcSEcCtD
Celecoxib—Vomiting—Enalapril—coronary artery disease	9.64e-06	0.000137	CcSEcCtD
Celecoxib—Dizziness—Captopril—coronary artery disease	9.62e-06	0.000137	CcSEcCtD
Celecoxib—Rash—Trandolapril—coronary artery disease	9.6e-06	0.000137	CcSEcCtD
Celecoxib—Dermatitis—Trandolapril—coronary artery disease	9.59e-06	0.000136	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Timolol—coronary artery disease	9.58e-06	0.000136	CcSEcCtD
Celecoxib—Fatigue—Timolol—coronary artery disease	9.57e-06	0.000136	CcSEcCtD
Celecoxib—Rash—Enalapril—coronary artery disease	9.56e-06	0.000136	CcSEcCtD
Celecoxib—Dermatitis—Enalapril—coronary artery disease	9.55e-06	0.000136	CcSEcCtD
Celecoxib—Headache—Trandolapril—coronary artery disease	9.54e-06	0.000136	CcSEcCtD
Celecoxib—Vomiting—Telmisartan—coronary artery disease	9.51e-06	0.000135	CcSEcCtD
Celecoxib—Asthenia—Losartan—coronary artery disease	9.5e-06	0.000135	CcSEcCtD
Celecoxib—Headache—Enalapril—coronary artery disease	9.5e-06	0.000135	CcSEcCtD
Celecoxib—Nausea—Niacin—coronary artery disease	9.46e-06	0.000135	CcSEcCtD
Celecoxib—Rash—Telmisartan—coronary artery disease	9.43e-06	0.000134	CcSEcCtD
Celecoxib—Dermatitis—Telmisartan—coronary artery disease	9.42e-06	0.000134	CcSEcCtD
Celecoxib—Diarrhoea—Furosemide—coronary artery disease	9.39e-06	0.000134	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	9.38e-06	0.000134	CcSEcCtD
Celecoxib—Pruritus—Losartan—coronary artery disease	9.37e-06	0.000133	CcSEcCtD
Celecoxib—Headache—Telmisartan—coronary artery disease	9.37e-06	0.000133	CcSEcCtD
Celecoxib—Feeling abnormal—Ramipril—coronary artery disease	9.36e-06	0.000133	CcSEcCtD
Celecoxib—Dizziness—Perindopril—coronary artery disease	9.34e-06	0.000133	CcSEcCtD
Celecoxib—Insomnia—Lisinopril—coronary artery disease	9.31e-06	0.000133	CcSEcCtD
Celecoxib—Nausea—Pravastatin—coronary artery disease	9.31e-06	0.000132	CcSEcCtD
Celecoxib—Gastrointestinal pain—Ramipril—coronary artery disease	9.28e-06	0.000132	CcSEcCtD
Celecoxib—Paraesthesia—Lisinopril—coronary artery disease	9.25e-06	0.000132	CcSEcCtD
Celecoxib—Vomiting—Captopril—coronary artery disease	9.24e-06	0.000132	CcSEcCtD
Celecoxib—Dyspnoea—Lisinopril—coronary artery disease	9.18e-06	0.000131	CcSEcCtD
Celecoxib—Rash—Captopril—coronary artery disease	9.17e-06	0.00013	CcSEcCtD
Celecoxib—Dermatitis—Captopril—coronary artery disease	9.16e-06	0.00013	CcSEcCtD
Celecoxib—Somnolence—Lisinopril—coronary artery disease	9.15e-06	0.00013	CcSEcCtD
Celecoxib—Feeling abnormal—Timolol—coronary artery disease	9.15e-06	0.00013	CcSEcCtD
Celecoxib—Headache—Captopril—coronary artery disease	9.11e-06	0.00013	CcSEcCtD
Celecoxib—Gastrointestinal pain—Timolol—coronary artery disease	9.08e-06	0.000129	CcSEcCtD
Celecoxib—Dizziness—Furosemide—coronary artery disease	9.08e-06	0.000129	CcSEcCtD
Celecoxib—Dyspepsia—Lisinopril—coronary artery disease	9.06e-06	0.000129	CcSEcCtD
Celecoxib—Diarrhoea—Losartan—coronary artery disease	9.06e-06	0.000129	CcSEcCtD
Celecoxib—Nausea—Trandolapril—coronary artery disease	9.04e-06	0.000129	CcSEcCtD
Celecoxib—Urticaria—Ramipril—coronary artery disease	9.02e-06	0.000128	CcSEcCtD
Celecoxib—Nausea—Enalapril—coronary artery disease	9e-06	0.000128	CcSEcCtD
Celecoxib—Vomiting—Perindopril—coronary artery disease	8.98e-06	0.000128	CcSEcCtD
Celecoxib—Body temperature increased—Ramipril—coronary artery disease	8.98e-06	0.000128	CcSEcCtD
Celecoxib—Abdominal pain—Ramipril—coronary artery disease	8.98e-06	0.000128	CcSEcCtD
Celecoxib—Decreased appetite—Lisinopril—coronary artery disease	8.95e-06	0.000127	CcSEcCtD
Celecoxib—Rash—Perindopril—coronary artery disease	8.9e-06	0.000127	CcSEcCtD
Celecoxib—Dermatitis—Perindopril—coronary artery disease	8.89e-06	0.000127	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Lisinopril—coronary artery disease	8.89e-06	0.000127	CcSEcCtD
Celecoxib—Nausea—Telmisartan—coronary artery disease	8.88e-06	0.000126	CcSEcCtD
Celecoxib—Fatigue—Lisinopril—coronary artery disease	8.88e-06	0.000126	CcSEcCtD
Celecoxib—Headache—Perindopril—coronary artery disease	8.84e-06	0.000126	CcSEcCtD
Celecoxib—Urticaria—Timolol—coronary artery disease	8.82e-06	0.000125	CcSEcCtD
Celecoxib—Constipation—Lisinopril—coronary artery disease	8.81e-06	0.000125	CcSEcCtD
Celecoxib—Body temperature increased—Timolol—coronary artery disease	8.77e-06	0.000125	CcSEcCtD
Celecoxib—Abdominal pain—Timolol—coronary artery disease	8.77e-06	0.000125	CcSEcCtD
Celecoxib—Dizziness—Losartan—coronary artery disease	8.76e-06	0.000125	CcSEcCtD
Celecoxib—Vomiting—Furosemide—coronary artery disease	8.73e-06	0.000124	CcSEcCtD
Celecoxib—Rash—Furosemide—coronary artery disease	8.65e-06	0.000123	CcSEcCtD
Celecoxib—Dermatitis—Furosemide—coronary artery disease	8.65e-06	0.000123	CcSEcCtD
Celecoxib—Nausea—Captopril—coronary artery disease	8.64e-06	0.000123	CcSEcCtD
Celecoxib—Headache—Furosemide—coronary artery disease	8.6e-06	0.000122	CcSEcCtD
Celecoxib—Feeling abnormal—Lisinopril—coronary artery disease	8.49e-06	0.000121	CcSEcCtD
Celecoxib—Gastrointestinal pain—Lisinopril—coronary artery disease	8.42e-06	0.00012	CcSEcCtD
Celecoxib—Vomiting—Losartan—coronary artery disease	8.42e-06	0.00012	CcSEcCtD
Celecoxib—Nausea—Perindopril—coronary artery disease	8.39e-06	0.000119	CcSEcCtD
Celecoxib—Hypersensitivity—Ramipril—coronary artery disease	8.37e-06	0.000119	CcSEcCtD
Celecoxib—Rash—Losartan—coronary artery disease	8.35e-06	0.000119	CcSEcCtD
Celecoxib—Dermatitis—Losartan—coronary artery disease	8.34e-06	0.000119	CcSEcCtD
Celecoxib—Headache—Losartan—coronary artery disease	8.3e-06	0.000118	CcSEcCtD
Celecoxib—Urticaria—Lisinopril—coronary artery disease	8.18e-06	0.000116	CcSEcCtD
Celecoxib—Hypersensitivity—Timolol—coronary artery disease	8.18e-06	0.000116	CcSEcCtD
Celecoxib—Nausea—Furosemide—coronary artery disease	8.15e-06	0.000116	CcSEcCtD
Celecoxib—Asthenia—Ramipril—coronary artery disease	8.15e-06	0.000116	CcSEcCtD
Celecoxib—Body temperature increased—Lisinopril—coronary artery disease	8.14e-06	0.000116	CcSEcCtD
Celecoxib—Abdominal pain—Lisinopril—coronary artery disease	8.14e-06	0.000116	CcSEcCtD
Celecoxib—Pruritus—Ramipril—coronary artery disease	8.03e-06	0.000114	CcSEcCtD
Celecoxib—Asthenia—Timolol—coronary artery disease	7.96e-06	0.000113	CcSEcCtD
Celecoxib—Nausea—Losartan—coronary artery disease	7.87e-06	0.000112	CcSEcCtD
Celecoxib—Pruritus—Timolol—coronary artery disease	7.85e-06	0.000112	CcSEcCtD
Celecoxib—Diarrhoea—Ramipril—coronary artery disease	7.77e-06	0.000111	CcSEcCtD
Celecoxib—Diarrhoea—Timolol—coronary artery disease	7.59e-06	0.000108	CcSEcCtD
Celecoxib—Hypersensitivity—Lisinopril—coronary artery disease	7.59e-06	0.000108	CcSEcCtD
Celecoxib—Dizziness—Ramipril—coronary artery disease	7.51e-06	0.000107	CcSEcCtD
Celecoxib—Asthenia—Lisinopril—coronary artery disease	7.39e-06	0.000105	CcSEcCtD
Celecoxib—Dizziness—Timolol—coronary artery disease	7.34e-06	0.000104	CcSEcCtD
Celecoxib—Pruritus—Lisinopril—coronary artery disease	7.29e-06	0.000104	CcSEcCtD
Celecoxib—Vomiting—Ramipril—coronary artery disease	7.22e-06	0.000103	CcSEcCtD
Celecoxib—Rash—Ramipril—coronary artery disease	7.16e-06	0.000102	CcSEcCtD
Celecoxib—Dermatitis—Ramipril—coronary artery disease	7.15e-06	0.000102	CcSEcCtD
Celecoxib—Headache—Ramipril—coronary artery disease	7.11e-06	0.000101	CcSEcCtD
Celecoxib—Vomiting—Timolol—coronary artery disease	7.06e-06	0.0001	CcSEcCtD
Celecoxib—Diarrhoea—Lisinopril—coronary artery disease	7.05e-06	0.0001	CcSEcCtD
Celecoxib—Rash—Timolol—coronary artery disease	7e-06	9.96e-05	CcSEcCtD
Celecoxib—Dermatitis—Timolol—coronary artery disease	6.99e-06	9.95e-05	CcSEcCtD
Celecoxib—Headache—Timolol—coronary artery disease	6.95e-06	9.9e-05	CcSEcCtD
Celecoxib—Dizziness—Lisinopril—coronary artery disease	6.81e-06	9.69e-05	CcSEcCtD
Celecoxib—Nausea—Ramipril—coronary artery disease	6.74e-06	9.6e-05	CcSEcCtD
Celecoxib—Nausea—Timolol—coronary artery disease	6.59e-06	9.38e-05	CcSEcCtD
Celecoxib—Vomiting—Lisinopril—coronary artery disease	6.55e-06	9.32e-05	CcSEcCtD
Celecoxib—Rash—Lisinopril—coronary artery disease	6.49e-06	9.24e-05	CcSEcCtD
Celecoxib—Dermatitis—Lisinopril—coronary artery disease	6.49e-06	9.23e-05	CcSEcCtD
Celecoxib—Headache—Lisinopril—coronary artery disease	6.45e-06	9.18e-05	CcSEcCtD
Celecoxib—Nausea—Lisinopril—coronary artery disease	6.12e-06	8.7e-05	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—KDR—coronary artery disease	6.17e-07	1.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LDLR—coronary artery disease	6.15e-07	1.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	6.14e-07	1.17e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTT1—coronary artery disease	6.13e-07	1.17e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC9A1—coronary artery disease	6.13e-07	1.17e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLCB1—coronary artery disease	6.1e-07	1.17e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PDHA1—coronary artery disease	6.08e-07	1.16e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCLM—coronary artery disease	6.08e-07	1.16e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC9A1—coronary artery disease	6.08e-07	1.16e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTT1—coronary artery disease	6.08e-07	1.16e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCLC—coronary artery disease	6.06e-07	1.16e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CETP—coronary artery disease	6.06e-07	1.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ESR1—coronary artery disease	6.01e-07	1.15e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOB—coronary artery disease	6.01e-07	1.15e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCLC—coronary artery disease	6.01e-07	1.15e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CETP—coronary artery disease	6.01e-07	1.15e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—coronary artery disease	6e-07	1.15e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SDC1—coronary artery disease	5.99e-07	1.15e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	5.99e-07	1.14e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—coronary artery disease	5.96e-07	1.14e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SDC1—coronary artery disease	5.94e-07	1.14e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—F2—coronary artery disease	5.94e-07	1.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FN1—coronary artery disease	5.94e-07	1.13e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCA1—coronary artery disease	5.91e-07	1.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6ST—coronary artery disease	5.91e-07	1.13e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TXNRD1—coronary artery disease	5.89e-07	1.13e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP11B2—coronary artery disease	5.89e-07	1.13e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK1—coronary artery disease	5.88e-07	1.12e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HIF1A—coronary artery disease	5.88e-07	1.12e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKBIA—coronary artery disease	5.86e-07	1.12e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—coronary artery disease	5.84e-07	1.12e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC22A3—coronary artery disease	5.8e-07	1.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—coronary artery disease	5.76e-07	1.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—coronary artery disease	5.74e-07	1.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LPL—coronary artery disease	5.74e-07	1.1e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GOT1—coronary artery disease	5.73e-07	1.09e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GGT1—coronary artery disease	5.73e-07	1.09e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ARNTL—coronary artery disease	5.71e-07	1.09e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HADH—coronary artery disease	5.71e-07	1.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—KIT—coronary artery disease	5.68e-07	1.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOA1—coronary artery disease	5.68e-07	1.08e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PSMA6—coronary artery disease	5.66e-07	1.08e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PSMB5—coronary artery disease	5.66e-07	1.08e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PSMA6—coronary artery disease	5.61e-07	1.07e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PSMB5—coronary artery disease	5.61e-07	1.07e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.6e-07	1.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—coronary artery disease	5.6e-07	1.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CTGF—coronary artery disease	5.53e-07	1.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CTGF—coronary artery disease	5.48e-07	1.05e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMGCR—coronary artery disease	5.48e-07	1.05e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GOT2—coronary artery disease	5.48e-07	1.05e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CD36—coronary artery disease	5.45e-07	1.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GSK3B—coronary artery disease	5.45e-07	1.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMGCR—coronary artery disease	5.43e-07	1.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GOT2—coronary artery disease	5.43e-07	1.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX2—coronary artery disease	5.42e-07	1.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA2—coronary artery disease	5.42e-07	1.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	5.42e-07	1.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—coronary artery disease	5.41e-07	1.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CREB1—coronary artery disease	5.41e-07	1.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6ST—coronary artery disease	5.39e-07	1.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPP2CA—coronary artery disease	5.38e-07	1.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.35e-07	1.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.35e-07	1.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX4—coronary artery disease	5.35e-07	1.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HK1—coronary artery disease	5.35e-07	1.02e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—coronary artery disease	5.35e-07	1.02e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—coronary artery disease	5.32e-07	1.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—coronary artery disease	5.29e-07	1.01e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HADHA—coronary artery disease	5.29e-07	1.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6R—coronary artery disease	5.27e-07	1.01e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PIK3CA—coronary artery disease	5.26e-07	1.01e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTA1—coronary artery disease	5.23e-07	9.99e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—coronary artery disease	5.2e-07	9.94e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—KIT—coronary artery disease	5.18e-07	9.91e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—coronary artery disease	5.18e-07	9.9e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPA—coronary artery disease	5.17e-07	9.88e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—coronary artery disease	5.17e-07	9.87e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—coronary artery disease	5.15e-07	9.84e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PIK3CA—coronary artery disease	5.11e-07	9.76e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARGC1A—coronary artery disease	5.1e-07	9.74e-06	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—coronary artery disease	5.1e-07	9.74e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—coronary artery disease	5.07e-07	9.7e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLCB1—coronary artery disease	5.04e-07	9.63e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAT—coronary artery disease	5.01e-07	9.57e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.01e-07	9.57e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLCB1—coronary artery disease	4.99e-07	9.55e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GSK3B—coronary artery disease	4.97e-07	9.51e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA5—coronary artery disease	4.95e-07	9.47e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—coronary artery disease	4.94e-07	9.44e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CREB1—coronary artery disease	4.93e-07	9.43e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—coronary artery disease	4.91e-07	9.38e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.9e-07	9.37e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCA1—coronary artery disease	4.88e-07	9.34e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOB—coronary artery disease	4.86e-07	9.29e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—P4HB—coronary artery disease	4.86e-07	9.29e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCA1—coronary artery disease	4.84e-07	9.25e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6R—coronary artery disease	4.81e-07	9.2e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—coronary artery disease	4.81e-07	9.19e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—FGF2—coronary artery disease	4.78e-07	9.14e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.77e-07	9.12e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOA1—coronary artery disease	4.75e-07	9.09e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—coronary artery disease	4.75e-07	9.09e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GGT1—coronary artery disease	4.73e-07	9.04e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GOT1—coronary artery disease	4.73e-07	9.04e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK1—coronary artery disease	4.73e-07	9.04e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—coronary artery disease	4.73e-07	9.04e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—coronary artery disease	4.72e-07	9.01e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GOT1—coronary artery disease	4.69e-07	8.96e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GGT1—coronary artery disease	4.69e-07	8.96e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK1—coronary artery disease	4.66e-07	8.91e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LPL—coronary artery disease	4.64e-07	8.87e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JAK2—coronary artery disease	4.58e-07	8.76e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.55e-07	8.7e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—coronary artery disease	4.53e-07	8.66e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—coronary artery disease	4.52e-07	8.64e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—coronary artery disease	4.51e-07	8.61e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—VCAN—coronary artery disease	4.5e-07	8.59e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.46e-07	8.53e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CD36—coronary artery disease	4.41e-07	8.43e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—FGF2—coronary artery disease	4.36e-07	8.34e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPP2CA—coronary artery disease	4.35e-07	8.32e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DCN—coronary artery disease	4.33e-07	8.28e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—coronary artery disease	4.3e-07	8.22e-06	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—coronary artery disease	4.3e-07	8.21e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—coronary artery disease	4.25e-07	8.12e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.21e-07	8.05e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—coronary artery disease	4.21e-07	8.05e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	4.21e-07	8.05e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—coronary artery disease	4.19e-07	8.01e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—coronary artery disease	4.19e-07	8.01e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—coronary artery disease	4.18e-07	8e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JAK2—coronary artery disease	4.18e-07	7.99e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—coronary artery disease	4.18e-07	7.99e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	4.17e-07	7.98e-06	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—coronary artery disease	4.17e-07	7.97e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—coronary artery disease	4.15e-07	7.94e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAT—coronary artery disease	4.13e-07	7.9e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—coronary artery disease	4.13e-07	7.9e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LIPC—coronary artery disease	4.11e-07	7.85e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HBA1—coronary artery disease	4.11e-07	7.85e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.11e-07	7.85e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.11e-07	7.85e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PIK3CA—coronary artery disease	4.1e-07	7.84e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAT—coronary artery disease	4.1e-07	7.83e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOC3—coronary artery disease	4.08e-07	7.8e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LDLR—coronary artery disease	4.06e-07	7.75e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CA—coronary artery disease	4.04e-07	7.73e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOB—coronary artery disease	4.01e-07	7.67e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.01e-07	7.66e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.01e-07	7.66e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—coronary artery disease	4e-07	7.65e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOB—coronary artery disease	3.98e-07	7.61e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—coronary artery disease	3.97e-07	7.59e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CETP—coronary artery disease	3.96e-07	7.57e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCLC—coronary artery disease	3.96e-07	7.57e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SDC1—coronary artery disease	3.92e-07	7.49e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—coronary artery disease	3.9e-07	7.46e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—coronary artery disease	3.9e-07	7.45e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—coronary artery disease	3.89e-07	7.44e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—coronary artery disease	3.87e-07	7.4e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOA1—coronary artery disease	3.85e-07	7.35e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPL—coronary artery disease	3.83e-07	7.33e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPL—coronary artery disease	3.8e-07	7.26e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—coronary artery disease	3.78e-07	7.23e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—coronary artery disease	3.77e-07	7.2e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—coronary artery disease	3.74e-07	7.15e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—coronary artery disease	3.71e-07	7.08e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.7e-07	7.07e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.7e-07	7.07e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.68e-07	7.04e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CD36—coronary artery disease	3.64e-07	6.96e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—coronary artery disease	3.63e-07	6.95e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CTGF—coronary artery disease	3.61e-07	6.91e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CD36—coronary artery disease	3.61e-07	6.9e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—coronary artery disease	3.6e-07	6.89e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPP2CA—coronary artery disease	3.6e-07	6.87e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.58e-07	6.85e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GOT2—coronary artery disease	3.58e-07	6.85e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPP2CA—coronary artery disease	3.56e-07	6.81e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—coronary artery disease	3.45e-07	6.6e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—coronary artery disease	3.42e-07	6.54e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—coronary artery disease	3.4e-07	6.49e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—coronary artery disease	3.39e-07	6.48e-06	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—coronary artery disease	3.35e-07	6.41e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—coronary artery disease	3.34e-07	6.39e-06	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—coronary artery disease	3.33e-07	6.37e-06	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—coronary artery disease	3.3e-07	6.32e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.29e-07	6.3e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—coronary artery disease	3.28e-07	6.27e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—coronary artery disease	3.25e-07	6.21e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—coronary artery disease	3.21e-07	6.14e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.19e-07	6.1e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—coronary artery disease	3.18e-07	6.09e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA1—coronary artery disease	3.18e-07	6.07e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA1—coronary artery disease	3.15e-07	6.02e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—coronary artery disease	3.12e-07	5.96e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GGT1—coronary artery disease	3.09e-07	5.91e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GOT1—coronary artery disease	3.09e-07	5.91e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK1—coronary artery disease	3.06e-07	5.84e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.01e-07	5.76e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—coronary artery disease	2.91e-07	5.57e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—coronary artery disease	2.84e-07	5.44e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—coronary artery disease	2.8e-07	5.35e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK1—coronary artery disease	2.79e-07	5.33e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.78e-07	5.31e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—coronary artery disease	2.77e-07	5.3e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—coronary artery disease	2.76e-07	5.27e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.75e-07	5.26e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.74e-07	5.24e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—coronary artery disease	2.74e-07	5.23e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAT—coronary artery disease	2.7e-07	5.17e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—coronary artery disease	2.67e-07	5.1e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CA—coronary artery disease	2.65e-07	5.07e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOB—coronary artery disease	2.62e-07	5.02e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.55e-07	4.88e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—coronary artery disease	2.52e-07	4.81e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPL—coronary artery disease	2.51e-07	4.79e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—coronary artery disease	2.49e-07	4.77e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—coronary artery disease	2.44e-07	4.67e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PIK3CA—coronary artery disease	2.42e-07	4.63e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—coronary artery disease	2.41e-07	4.6e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—coronary artery disease	2.39e-07	4.56e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CD36—coronary artery disease	2.38e-07	4.55e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.35e-07	4.49e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—coronary artery disease	2.35e-07	4.49e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.26e-07	4.31e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—coronary artery disease	2.2e-07	4.21e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.18e-07	4.17e-06	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—coronary artery disease	2.17e-07	4.14e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—coronary artery disease	2.14e-07	4.1e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—coronary artery disease	2.14e-07	4.1e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—coronary artery disease	2.1e-07	4.01e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA1—coronary artery disease	2.08e-07	3.97e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CA—coronary artery disease	2.03e-07	3.87e-06	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—coronary artery disease	1.98e-07	3.78e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—coronary artery disease	1.83e-07	3.5e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—coronary artery disease	1.8e-07	3.45e-06	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—coronary artery disease	1.66e-07	3.17e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—coronary artery disease	1.64e-07	3.14e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CA—coronary artery disease	1.64e-07	3.13e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—coronary artery disease	1.57e-07	3.01e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.44e-07	2.75e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CA—coronary artery disease	1.35e-07	2.59e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.34e-07	2.57e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—coronary artery disease	1.34e-07	2.56e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—coronary artery disease	1.11e-07	2.11e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—coronary artery disease	1.1e-07	2.1e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	8.85e-08	1.69e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—coronary artery disease	7.23e-08	1.38e-06	CbGpPWpGaD
